COLUMBIA LABORATORIES TO DISCUSSFOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS ON MARCH 5, 2009 CONFERENCE CALL

Columbia Laboratories's picture
Printer-friendly versionPrinter-friendly versionPDF versionPDF version

LIVINGSTON, NJ— March 3, 2009—Columbia Laboratories, Inc. (Nasdaq: CBRX) will hold a conference call on March 5, 2009 to discuss financial results of the fourth quarter and year ended December 31, 2008. Robert S. Mills, president and chief executive officer, and James A. Meer, senior vice president, chief financial officer and treasurer of Columbia Laboratories, will host the call. 

style="border-collapse: collapse; border: medium none; margin-left: 6.75pt; margin-right: 6.75pt">

style="width: 1.2in; height: 13.95pt; border: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">

Date:

style="width: 315.0pt; height: 13.95pt; border-left: medium none; border-right: 1.0pt solid white; border-top: 1.0pt solid white; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">

March 5, 2009

style="width: 1.2in; height: 13.85pt; border-left: 1.0pt solid white; border-right: 1.0pt solid white; border-top: medium none; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">

Time:

style="width: 315.0pt; height: 13.85pt; border-left: medium none; border-right: 1.0pt solid white; border-top: medium none; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">

11:00 AM ET

style="width: 1.2in; height: 13.85pt; border-left: 1.0pt solid white; border-right: 1.0pt solid white; border-top: medium none; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">

Dial-in Numbers:

style="width: 315.0pt; height: 13.85pt; border-left: medium none; border-right: 1.0pt solid white; border-top: medium none; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">

800-289-0438 (U.S. & Canada) or 913-312-0658

style="width: 1.2in; height: 13.85pt; border-left: 1.0pt solid white; border-right: 1.0pt solid white; border-top: medium none; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">

Live webcast:

style="width: 315.0pt; height: 13.85pt; border-left: medium none; border-right: 1.0pt solid white; border-top: medium none; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">

href="http://www.cbrxir.com/events.htm">www.cbrxir.com

, under “Events”

 

 

 

The teleconference replay will be available two hours after completion through Thursday, March 12, 2009 at 888-203-1112 (U.S. & Canada) or 719-457-0820. The replay passcode is 5195475. The archived webcast will be available for one year on the Company’s investor website,www.cbrxir.com, under "Events."
 

About Columbia Laboratories

Columbia Laboratories, Inc. is a specialty pharmaceutical company focused on developing and marketing products for the reproductive healthcare and endocrinology markets using its novel bioadhesive drug delivery technology. For more information, please visitwww.columbialabs.com.

 

###

Company Contact: 

Investor and Media Contact: 

James A. Meer

Melody A. Carey,

Senior Vice President,CFO & Treasurer

Co-President, Rx Communications, LLC

(973) 486-8860

(917) 322-2571

News Source : COLUMBIA LABORATORIES TO DISCUSSFOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS ON MARCH 5, 2009 CONFERENCE CALL


Copy this html code to your website/blog and link to this press release.